JSC Grindeks confirms that the turnover of the company’s (not the Group’s) self-manufactured products in 2012 was 55.5 million lats, based on the State Agency...
Environmental Control Laboratory of JSC Grindeks has received the accreditation certificate ISO 17025 from the Latvian National Accreditation Bureau. The received accreditation certifies the proficiency...
Today, on 28 November 2012, in Riga, 53 Krustils Street, JSC Grindeks has solemnly unveiled a manufacturing unit of ointments and gels, which is one...
Today, on 8 November, within the framework of the World Science Day, JSC Grindeks fund “For the Support of Science and Education” in cooperation with...
Grindeks’ Main fields of action are research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. Grindeks Group consists of 4 subsidiary companies...
JSC Grindeks informs that today, on 21 September, the delegation of Japanese entrepreneurs is visiting the company. The visit is within the framework of the...
From 9 to 11 October, 2012, Grindeks will participate in the international exhibition “CPhI Worldwide 2012” in Madrid, Spain. During the exhibition Grindeks will meet...
International conference “Life Sciences Baltics 2012” takes place in Vilnius, Lithuania from 12 until 14 September, where, besides other leading pharmaceutical specialists, Chairman of the...
On 7-9 September, the International Medical Meeting (IMM-Riga 2012) will take place in the University of Latvia in Riga, Latvia. In the IMM, scientists will...
